Is there still place for VAD as primary treatment for patients with multiple myeloma who are candidates for high-dose therapy?
| Image |  |
|---|---|
| Description | scientific article published in January 2006 |
| Author/s | |
| Publication date | January 2006 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |